Literature DB >> 9271085

Accumulation of pro-apolipoprotein A-II in mouse senile amyloid fibrils.

K Higuchi1, K Kogishi, J Wang, C Xia, T Chiba, T Matsushita, M Hosokawa.   

Abstract

Apolipoprotein A-II (apoA-II), the major apoprotein of serum high-density lipoprotein, is deposited as amyloid fibrils (AApoAII) in murine senile amyloidosis. We have identified and purified a more basic amyloid protein from old-mouse liver. N-terminal sequencing of the protein revealed that the pro-segment of five amino acid residues (Ala-Leu-Val-Lys-Arg) extended from the N-terminal glutamine residue of mature apoA-II protein. MS analysis revealed the deposit of intact pro-apoA-II protein (molecular mass 9319 Da). Antiserum was prepared for staining of the AApoAII amyloid deposition. The relative abundance of pro-apoA-II to mature apoA-II in the amyloid-fibril fraction isolated from livers of mice with severe amyloidosis was 14.1%. The similar abundance of pro-apoA-II in the amyloid fibril fraction from the spleen (16.3%) suggested that deposited pro-apoA-II originated from the blood. The concentration of pro-apoA-II was much lower in the serum (1.5% of mature apoA-II) than in the amyloid-fibril fraction. There was no difference in the content of pro-apoA-II between the amyloidogenetic R1.P1-Apoa2c and amyloid-resistant SAMR1 strains at the age of 3 months. The abundance of pro-apoA-II in the amyloid-fibril fraction compared with the serum suggested that it plays a key role in the initialization of mouse senile amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271085      PMCID: PMC1218608          DOI: 10.1042/bj3250653

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  PHD: predicting one-dimensional protein structure by profile-based neural networks.

Authors:  B Rost
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

3.  Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.

Authors:  K Ganowiak; P Hultman; U Engström; A Gustavsson; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  1994-02-28       Impact factor: 3.575

4.  Association of apolipoprotein E with murine amyloid A protein amyloid.

Authors:  M S Kindy; A R King; G Perry; M C de Beer; F C de Beer
Journal:  Lab Invest       Date:  1995-10       Impact factor: 5.662

5.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

Authors:  N Suzuki; T T Cheung; X D Cai; A Odaka; L Otvos; C Eckman; T E Golde; S G Younkin
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

6.  Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques.

Authors:  H Fukumoto; A Asami-Odaka; N Suzuki; H Shimada; Y Ihara; T Iwatsubo
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Accelerated senile amyloidosis induced by amyloidogenic Apoa-II gene shortens the life span of mice but does not accelerate the rate of senescence.

Authors:  K Higuchi; J Wang; K Kitagawa; T Matsushita; K Kogishi; H Naiki; H Kitado; M Hosokawa
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-07       Impact factor: 6.053

8.  A high resolution ultrastructural study of experimental murine AA amyloid.

Authors:  S Inoue; R Kisilevsky
Journal:  Lab Invest       Date:  1996-03       Impact factor: 5.662

9.  Non-genetic propagation of strain-specific properties of scrapie prion protein.

Authors:  R A Bessen; D A Kocisko; G J Raymond; S Nandan; P T Lansbury; B Caughey
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

10.  Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene.

Authors:  W A Gonnerman; R Elliott-Bryant; I Carreras; J D Sipe; E S Cathcart
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  4 in total

1.  Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

Review 2.  Animal models of human amyloidoses: are transgenic mice worth the time and trouble?

Authors:  Joel N Buxbaum
Journal:  FEBS Lett       Date:  2009-07-20       Impact factor: 4.124

3.  Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant.

Authors:  Tatiana Prokaeva; Harun Akar; Brian Spencer; Andrea Havasi; Haili Cui; Carl J O'Hara; Olga Gursky; John Leszyk; Martin Steffen; Sabrina Browning; Allison Rosenberg; Lawreen H Connors
Journal:  Kidney Int Rep       Date:  2017-07-29

4.  Exercise suppresses mouse systemic AApoAII amyloidosis through enhancement of the p38 MAPK signaling pathway.

Authors:  Xiaoran Cui; Jinko Sawashita; Jian Dai; Chang Liu; Yuichi Igarashi; Masayuki Mori; Hiroki Miyahara; Keiichi Higuchi
Journal:  Dis Model Mech       Date:  2022-03-21       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.